High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof Read more about High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof Japan2019-000195Filed on 2013-05-31
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Patent Cooperation TreatyPCT/US2019/017354Filed on 2019-02-08
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Japan2018-243703Filed on 2018-12-26
Papillomavirus Pseudoviruses for Detection and Therapy of Tumors Read more about Papillomavirus Pseudoviruses for Detection and Therapy of Tumors US Patent 10,814,014Filed on 2018-12-28
Nanoparticle to Target Cancer Read more about Nanoparticle to Target Cancer European Patent17767463.7Filed on 2017-03-15
Anti-cancer Activity Of SCGB3A2 Read more about Anti-cancer Activity Of SCGB3A2 Patent Cooperation TreatyPCT/US2019/014189Filed on 2019-01-18
Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor Read more about Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor Australia2018274874Filed on 2018-12-04
Synergistic Therapeutic Antitumor Effect Of HMGN1 With Other Antitumor Treatments Read more about Synergistic Therapeutic Antitumor Effect Of HMGN1 With Other Antitumor Treatments US Patent 11,266,746Filed on 2017-02-24
Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments Read more about Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments Canada3028654Filed on 2017-02-24
Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments Read more about Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments Australia2017289450Filed on 2017-02-24